MedTech Innovator sets a $15,000 cash fee or $50,000 SAFE for its main cohort, with applications due December 1, 2026
MedTech Innovator’s 2027 accelerator is free to apply to, but joining the main cohort comes with a choice: pay $15,000 upfront or in two equal installments, or sign a $50,000 SAFE before acceptance. Early- to mid-stage medical device, diagnostics and digital health companies can apply to MedTech Innovator from anywhere in the world if they target the U.S. market. Companies can start by creating a profile in the portal linked from the official application page. Applications close December 1, 2026, and the organizer expects to notify applicants in late May 2027.

What joining could cost
A SAFE, or simple agreement for future equity, can convert into shares under terms set in the agreement. The cash fee is a known outlay before any scholarship, while the published SAFE amount does not tell founders how much ownership they might give up. MedTech Innovator lists the $50,000 SAFE as an alternative to paying the participation fee in cash, not among the announced competition prizes. Its public call and November 19 briefing do not specify how the SAFE converts, whether a company receives cash for it or how a scholarship would affect it.
The call says qualifying companies can receive scholarships at acceptance and that payment may be deferred case by case. In its November 19 briefing led by program director Nicole Black, MedTech Innovator said every company in the 2026 cohort received at least $7,500 in scholarship support. The 2027 call does not promise that minimum.
The American Heart Association and American Society of Plastic Surgeons specialty tracks require a $50,000 SAFE. For the Vantage track, the organizer says a BARDA scholarship covers the full program fee.
